查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球動物輸液泵市場-2022-2029
市場調查報告書
商品編碼
1129271

全球動物輸液泵市場-2022-2029

Global Veterinary Infusion Pumps Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

獸醫輸液泵是用於為重症寵物長時間提供營養液的設備，並且是劑量時尚的。獸醫輸液泵已成為體液監測和分析各種動物臨床問題的一個組成部分。它是一種定期向患者體內輸送精確數量的營養、藥物和液體的方法。這些泵的推注、預編程和待機模式功能可以完全改變血液製品的給藥方式。

市場動態

動物輸液泵的技術創新有望推動市場增長。

新的藥劑，例如某些生物製劑、基因療法和其他不能口服、局部或靜脈內給藥的小分子，需要在植入式給藥系統方面取得進步。這種侵入性給藥策略直接克服了動物身體構成的生理障礙，將適量的藥物釋放到治療部位，並在給藥後所需的時間內保持藥物的生物活性，以確保藥物療效。保持可用性。微技術的進步使現代 MEMS 植入式藥物輸液泵具有獨特的性能和特點。急性快速放射性標記、用於癌症治療的納米藥物的短期給藥和慢性眼部藥物給藥是微泵在實驗室動物和臨床前研究中體內演示的一些例子。此外，微結構研究，如 MEMS 致動器和閥門，可能會導致下一代植入式泵體積小、性能優異，適用於臨床應用。因此，從上述陳述來看，預計它將成為預測期內市場的驅動力。

約束

動物輸液泵的高成本、對設備批准的嚴格規定、動物主人缺乏動物健康意識、使用不同給藥裝置的輸液泵錯誤等將在預測期內阻礙市場。預期因素。

行業分析

動物輸液泵市場根據供應鏈分析、價格分析等各種行業因素對市場進行了深入分析。

COVID-19 影響分析

COVID-19 大流行對醫療保健系統和市場產生了適度影響。出於治療或診斷目的，輸液泵是一種通過靜脈 (IV) 或硬膜外方法精確輸送液體的機器。與重力計量裝置相比，提供更高的壓力和更高的精度。輸液泵對寵物構成重大風險，因此在管理輸液和藥物時應格外小心。如果輸液速度或容量設置不正確，患者可能會受到傷害。使用任何輸液設備時，監控您的寵物非常重要。

另一方面，經濟危機將影響農業和獸醫服務，更加強調冠狀病毒感染對農場和寵物動物的公共衛生影響。此外，大流行將破壞供應鍊和流程。許多公司將轉移到其他地區以確保產品可用性並保護其供應鏈。因此，從上面這句話來看，市場受到了影響，預計隨著經濟活動的恢復，市場將迅速獲得牽引力。

全球動物輸液泵市場報告將提供對大約 45 多個市場數據表、40 多個數字和 200 頁的訪問。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

  • 市場影響因子
    • 驅動程序
      • 動物輸液泵的技術創新有望推動市場增長。
    • 限制因素
      • 動物輸液泵的高成本預計將阻礙市場增長。
    • 機會
    • 影響分析

第五章行業分析

  • 供應鏈分析
  • 定價分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按類型

  • 大容量輸液泵
  • 注射器式輸液泵

第 8 章動人

  • 固定式
  • 便攜

第 9 章按渠道類型

  • 單通道
  • 多渠道

第十章註入方式

  • 費率模式
  • 時間模式
  • 劑量模式
  • 其他

第 11 章，最終用戶

  • 獸醫醫院
  • 獸醫醫院
  • 實驗室
  • 家庭護理
  • 其他

第 12 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 13 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 產品基準
  • 值得關注的重點公司列表

第 14 章公司簡介

  • B.Braun Melsungen AG
    • 公司簡介
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Burtons Medical Equipment Ltd
  • Digicare Biomedical Technology Inc
  • DRE Veterinary
  • Grady Medical System Inc.
  • Heska Corporation
  • Jorgen Kruuse
  • Jorgensen Laboratories
  • Eitan Medical
  • iVet Medical

第15章 全球動物輸液泵市場-DataM

簡介目錄
Product Code: DMVH5839

Market Overview

Veterinary Infusion Pumps Market size was valued US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

The veterinary infusion pump is a device used to deliver nutrient solutions to seriously ill pets over a lengthy period and is dosed fashioned. Veterinarian infusion pumps have been essential in monitoring and analyzing fluids for various clinical problems in animals. It administers a controlled supply of nutrition, drugs, and fluids to the patient's body in precise amounts at regular intervals. These pumps' bolus dosage, preprogramming, and standby mode capabilities can completely change how blood medicines are administered.

Market Dynamics

Innovations in Veterinary Infusion Pumps are expected to drive market growth.

Advancements in implanted drug delivery systems are necessary for novel pharmacological substances, such as particular biologics, gene therapy, and other tiny molecules that cannot be delivered orally, topically, or intravenously. This invasive dosing strategy aims to directly overcome physiological barriers posed by the animal body, release the appropriate medication dosage at the treatment site, and maintain the medication's bioavailability for the necessary period following delivery to ensure medication efficacy. Modern MEMS-enabled implanted medication infusion pumps with distinctive performance and feature sets have been made possible by microtechnological advancements. Acute fast radiolabeling, short-term administration of nanomedicine for cancer treatment, and chronic ocular medication dosage are a few examples of in vivo demonstration of micropumps for laboratory animal research and preclinical studies. Moreover, Next-generation implantable pumps with excellent performance in a small form factor for clinical applications may be made possible through research into MEMS actuators, valves, and other microstructures. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint

The high cost of veterinary infusion pumps, stringent regulations for the approvals of the devices, lack of awareness of animal health among the proprietors and errors of fluid infusion pumps using different administration sets are some of the factors the market is expected to get hampered in the forecast period.

Industry Analysis

The veterinary infusion pumps market provides in-depth analysis of the market based on various industry factors such as supply chain analysis, pricing analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. For therapeutic or diagnostic purposes, infusion pumps are machines that accurately provide liquids via intravenous (IV) or epidural methods. Compared to gravity administration sets, they offer higher pressures and greater accuracy. Infusion pumps provide a significant risk to pets, so extra caution should be used while administering IV solutions or medications. The patient may suffer harm if the infusion rate or volume are set incorrectly. Every infusion device should be utilized while the pets are being closely watched.

In contrast, an economic crisis will affect agriculture and veterinary services, and a greater emphasis on the public health effects of coronavirus infections in animals on farms and pets. Additionally, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of economic activities.

Segment Analysis

Large-Volume Infusion Pumps segment is expected to hold the largest market share in veterinary infusion pumps market

The large-volume infusion pumps segment is expected to dominate in 2021. The segment benefits as the infusion pumps can be manually or mechanically operated, offering great pain relief, fewer side effects than oral pharmaceutical treatment, and accessibility for daily tasks. Also, various infusion pumps are categorized into several categories based on their size, accuracy, technology, flow rate, battery life, and kind of infusions (continuous, intermittent). Therefore, it has led to the increased usage of large volume infusion pumps for administering parenteral nourishment, delivering fluid for blood transfusions, and in emergencies, with technological advancements in large volume infusion pumps. For instance, the IVVet Veterinary Infusion Pump from Eitan Medical combines the proprietary Flow Control Technology, state-of-the-art hardware design, user-friendly touch-screen, software-controlled pumping mechanism, and low total cost of ownership. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global veterinary infusion pumps market

In 2021, North America accounted for the highest revenue share. The significant growth rate is owing to the increase in animal adaptation rates and healthcare expenditure coupled with rising animal diseases requiring surgeries. The huge number of veterinary practices and product launches by the market players are some factors the market is expected to boost in the forecast period. For instance, according to the American Society for the Prevention of Cruelty to Animals, every year, almost 4.1 million pets are adopted from animal shelters. On average, 2.1 million cats and 2 million dogs are adopted yearly. In contrast to dogs, which are more frequently bought from breeders than adopted, cats are adopted more frequently than they are bought from breeders. Moreover, according to the Veterinary Medical Association 2020, as of December 2020, there were around 75,349 veterinarian private offices in the United States.

Additionally, to establish a national sales presence in the veterinary healthcare equipment industry, DVMPro Inc., a top supplier of veterinary diagnostic equipment for veterinary health professionals, partnered with MTMC Animal Health. The relationship between MTMC and DVMPro will cover the entire product line, which comprises Veterinary Monitoring, Ventilators & Anesthesia, Ultrasound, ECG, Infusion Pumps, Pulse Oximetry, and Blood Analysis. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the veterinary infusion pumps market are B. Braun Melsungen AG, Burtons Medical Equipment Ltd, Digicare Biomedical Technology Inc., DRE Veterinary, Grady Medical System Inc., Heska Corporation, Jorgen Kruuse, Jorgensen Laboratories, Eitan Medical, iVet Medical.

B. Braun Melsungen AG:

Overview:

B. Braun is a German manufacturer of medical and pharmaceutical devices. The B. Braun product line includes 5,000 items, 95 percent of which are manufactured by the company. The company's product portfolio includes infusion, nutrition, pain therapy products, infusion pumps and systems, surgical instruments, suture materials, hip and knee implants, dialysis equipment and accessories, ostomy, disinfection, and wound care products. The company operates its business through five divisions: hospital care, Aesculap, B. Braun Avitum, out-patient market (OPM) and other sales. B. Braun has a presence in 64 countries and develops products in 18 therapy fields of the healthcare industry.

Product Portfolio:

Infusomat Space pump: The Infusomat Space pump is a volumetric infusion pump configured as an individual pump, a small therapy unit, or an advanced infusion system. The pump's compact, lightweight, and user-friendly designs unify all clinical areas into a single system while offering a user-friendly solution to complex therapies.

The global veterinary infusion pumps market report would provide an access to an approx. 45+market data table, 40+figures and 200pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Innovations in Veterinary Infusion Pumps are expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. The high cost of veterinary infusion pumps is expected to hamper the market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Supply Chain Analysis
  • 5.2. Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type Segment
  • 7.2. Large-Volume Infusion Pumps*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Syringe Infusion Pumps

8. By Mobility

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mobility
    • 8.1.2. Market Attractiveness Index, By Mobility Segment
  • 8.2. Stationary*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Portable

9. By Channel Type

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Channel Type
    • 9.1.2. Market Attractiveness Index, By Channel Type Segment
  • 9.2. Single Channel*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Multi-Channel

10. By Infusion Mode

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Infusion Mode
    • 10.1.2. Market Attractiveness Index, By Infusion Mode Segment
  • 10.2. Rate Mode*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Time Mode
  • 10.4. Dose Mode
  • 10.5. Others

11. By End user

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.1.2. Market Attractiveness Index, By End user Segment
  • 11.2. Veterinary Hospitals*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 11.3. Veterinary Clinics
  • 11.4. Laboratories
  • 11.5. Homecare
  • 11.6. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mobility
    • 12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Channel Type
    • 12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Infusion Mode
    • 12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mobility
    • 12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Channel Type
    • 12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Infusion Mode
    • 12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. U.K.
      • 12.3.8.3. France
      • 12.3.8.4. Italy
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mobility
    • 12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Channel Type
    • 12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Infusion Mode
    • 12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mobility
    • 12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Channel Type
    • 12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Infusion Mode
    • 12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan
      • 12.5.8.4. Australia
      • 12.5.8.5. Rest of Asia Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mobility
    • 12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Channel Type
    • 12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Infusion Mode
    • 12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

13. Competitive Landscape

  • 13.1. Key Developments and Strategies
  • 13.2. Company Share Analysis
  • 13.3. Product Benchmarking
  • 13.4. List of Key Companies to Watch

14. Company Profiles

  • 14.1. B. Braun Melsungen AG*
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. Burtons Medical Equipment Ltd
  • 14.3. Digicare Biomedical Technology Inc
  • 14.4. DRE Veterinary
  • 14.5. Grady Medical System Inc.
  • 14.6. Heska Corporation
  • 14.7. Jorgen Kruuse
  • 14.8. Jorgensen Laboratories
  • 14.9. Eitan Medical
  • 14.10. iVet Medical

LIST NOT EXHAUSTIVE

15. Global Veterinary Infusion Pumps Market - DataM

  • 15.1. Appendix
  • 15.2. About Us and Applications
  • 15.3. Contact Us